newsfilter
← Latest News
Business Wire·

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack

  • Piper Sandler Companies (NYSE: PIPR) appointed Patrick McCormack, M.D. as a managing director in its healthcare investment banking group.
  • McCormack will be based in San Francisco and will advise biopharma companies on mergers, acquisitions, & capital-raising transactions.
  • Peter Day, global group head of healthcare investment banking, cited McCormack's deep expertise in equity & M&A transactions alongside his scientific & clinical perspective as key strengths.
  • McCormack previously served as an executive director in biopharma investment banking at Wells Fargo Securities.
  • His prior senior roles included positions at Goldman Sachs & Co., SVB Leerink, & SunTrust Robinson Humphrey.
  • McCormack holds a Doctor of Medicine degree from the University of Louisville School of Medicine with a residency in internal medicine & anesthesiology.
  • He earned a Master of Business Administration from Vanderbilt University & a bachelor's degree in microbiology & cell sciences from the University of Florida.
  • The announcement was issued on April 27, 2026, via Businesswire.